given the downstream position of MYC in these signaling cascades, the mechanism through which mTORC1 activity is downregulated in Myc +/− mice is not understood.
We report that the high-affinity glutamine transporter SLC1A5, which is critical for activation of mTORC1 activity by amino acids, is a transcriptional target of MYC.
Myc
+/− cells display decreased Slc1a5 gene expression that leads to lower glutamine uptake and consequently reduced mTORC1 activity. Decreased mTORC1 activity in turn mediates an elevation of fatty acid oxidation (FAO) by indirectly upregulating the expression of carnitine palmitoyltransferase 1a (Cpt1a) that mediates the rate-limiting step of β-oxidation. Increased FAO has been noted in a number of long-lived mouse models. Taken together, our results show that transcriptional feedback loops regulated by MYC modulate upstream signaling pathways such as mTOR and impact FAO on an organismal level.
K E Y W O R D S
fatty acid oxidation, genetic models, metabolic regulation, mouse longevity, mTOR signaling, MYC gene implicated both the Slc1a5 and Slc7a5 genes as direct MYC targets (Supporting Information Figure S2 ). Given the critical role of glutamine uptake in mTORC1 activation (Nicklin et al., 2009 ), we asked whether these genes are differentially regulated in Myc +/− animals.
The expression of Slc1a5 mRNA in the liver of Myc +/− mice was reduced 20%-30% compared to Myc +/+ mice ( Figure 1a ). This change was observed in vivo as well as in cultured primary mouse tail fibroblasts (MTF) and primary mouse hepatocytes (MHC). A similar downregulation of Slc7a5 was observed in Myc +/− fibroblasts and hepatocytes ( Figure 1b ).
Reduced Slc1a5 and Slc7a5 expression was accompanied by a decline in glutamine uptake and metabolism. Relative to Myc +/+ controls, MTF from Myc +/− mice showed a 40% decrease in the removal of glutamine from the medium (Figure 1c) , as well as a significant decrease in the production of glutamate and ammonia. A quantitative short-term uptake assay using a radioactive tracer ( 3 H-glutamine) showed a decrease in glutamine transport in Myc +/− MHC that paralleled the effects seen in MTF ( Figure 1d ). We also used l-γ-glutamyl-p-nitroanilide (GPNA), a competitive inhibitor of SLC1A5-mediated glutamine uptake (Esslinger, Cybulski, & Rhoderick, 2005) , (Hofmann et al., 2015) . To gain more molecular insight of this metabolic change, we examined Myc +/+ and Myc +/− mice under either ad libitum feeding conditions, or after overnight (16 hr) fasting prior to sacrifice. Since stored fatty acids are used as a major energy source during fasting, FAO is induced soon after food removal (Arias, Asins, Hegardt, & Serra, 1997; Kersten, Desvergne, & Wahli, 2000) . In our experiments, this was evidenced by a twofold upregulation, in both liver and skeletal muscle of fasted animals of both genotypes, of the gene encoding long-chain-acylCoA dehydrogenase (Acadl), a member of a family of mitochondrial flavoproteins that catalyze the initial steps of β-oxidation of straight chain fatty acyl-CoA (Figure 1e ,f). We also examined the peroxisome proliferator-activated receptor alpha (Ppara) gene, encoding a transcription factor that regulates ketogenesis (Kersten et al., 2000) , and found a fasting-induced increase in expression similar to that of the Acadl gene (Figure 1g ).
We then assessed the expression of the sterol regulatory ele- mice, but no differences were observed in fasted mice between the genotypes (Figure 1h ). In addition, while Srebf1 levels were induced (Figure 2a ). Hence, mTORC1 activity (Figure 2a) , suggesting that at least some of the effects are cell autonomous. To explore whether reduced mTORC1 activity could lead to increased FAO, we treated MTF with the mTORC1 inhibitor rapamycin. As expected, ribosomal protein S6 phosphorylation was decreased by rapamycin treatment (Supporting Information Figure S3 ). Interestingly, FAO was increased significantly in cells of both genotypes (Figure 2b) , and a similar phenomenon was also observed in MHC (Figure 2c ). Figure S4 ). Finally, we were also able to increase FAO with GPNA treatment in a third cell culture model, an immortalized were cultured in the absence or presence of 0.3 mM, 0.6 mM, and 1.2 mM GPNA for 24 hr. Cell cultures were established from individual animals as above, n = 5 for each treatment group. (f) AML-12 cells were cultured in the absence or presence of 2 mM GPNA for 24 hr. n = 3 independent cultures. Error bars represent SEM. Statistical significance was assessed using one-way ANOVA followed by Tukey's post hoc test for panels (a) and (d), (e), two-way ANOVA followed by Tukey's post hoc test for panels (b), (c), and Wilcoxon rank-sum test for panel (f). (g) MYC regulates the mTORC1 pathway through its direct transcriptional targets SLC1A5 and SLC7A5. mTORC1 activity is regulated post-translationally in part by the cytoplasmic levels of essential amino acids such as leucine. SLC1A5, a high-affinity glutamine transporter, transports glutamine into cells, some of which is subsequently exchanged for leucine by the SLC7A5 antiporter. Myc +/− cells express the Slc1a5 and Slc7a5 genes at a lower level, which leads to less glutamine uptake, lower intracellular levels of essential amino acids, and consequently reduced mTORC1 activity. Decreased mTORC1 activity in turn mediates an elevation of FAO (AML-12, Figure 2f ). These data indicate that reduced glutamine uptake is sufficient to downregulate mTOR signaling, which in turn promotes FAO.
In summary, we demonstrate here the existence of an indirect feedback loop by which MYC regulates the transcription of the Slc1A5 gene, whose gene product in turn modulates the activation status of mTORC1 kinase (Figure 2g ). The SLC1A5 transporter regulates the rate-limiting step of glutamine uptake, with the subsequent exchange of intracellular glutamine for essential amino acids being mediated by SLC7A5 and SLC3A2 (Nicklin et al., 2009) . Elevated MYC activity is well known to promote glutamine metabolism in the context of cancer by transcriptionally upregulating several glutamine transporters (including Slc1A5) and glutaminase (Gls) (Gao et al., 2009; Wise et al., 2008) . MYC mRNA and protein levels are both decreased by 40%-60% in Myc +/− mice and cells (Hofmann et al., 2015) ; correspondingly, we found Slc1a5 and Slc7a5 mRNA to be decreased by 20%-30% and glutamine uptake by 40% in both MTF and MHC. In agreement with our findings that this feedback loop can negatively affect mTORC1 activity, deletion of Myc was reported to impair mTORC1 signaling during T-cell activation (Wang et al., 2011) .
MYC thus regulates translation by at least two distinct mechanisms:
as a direct transcriptional activator of the entire ribosomal biogenesis regulon (Hofmann et al., 2015) and by the indirect feedback loop documented here that affects mTORC1 activation status.
Fatty acid oxidation is significantly elevated in Myc +/− mice (Hofmann et al., 2015) as well as in other lifespan-extending interventions, such as dietary restriction (Bruss, Khambatta, Ruby, Aggarwal, & Hellerstein, 2010) or knockout of the growth hormone receptor (Westbrook, Bonkowski, Strader, & Bartke, 2009) . FAO was increased by downregulating MYC in a human Burkitt's lymphoma B cell line (Le et al., 2012) , as well as by a Myc knockout in a rat fibroblast cell line (Edmunds et al., 2014) . The large magnitude of these effects was probably due to the large changes in MYC expression explored in these studies: very high starting levels of MYC in (Figure 1h ). Previous studies have suggested that mTORC1 regulates SREBPs at multiple levels, including transcription, processing, and nuclear accumulation of the active forms of these transcription factors (Bakan & Laplante, 2012) .
It is thus possible that the post-transcriptional regulation of SREBF1 by mTORC1 is more pronounced in Myc +/− mice. In addition, since we observed a marked reduction in AKT and mTORC1 signaling in Myc hypomorphic mice (Hofmann et al., 2015) , and both pathways promote lipid synthesis (Bakan & Laplante, 2012) , it is plausible that Myc +/− mice maintain a reduced level of lipid synthesis under ad lib conditions and do not further decrease it when subjected to shortterm starvation. Further study is required to tease out the possibilities behind this phenomenon.
Cpt1a mRNA and FAO levels increased dose-dependently when MHC were treated with GPNA, a competitive inhibitor of SLC1A5-regulated glutamine uptake (Figure 2d ). The discrepancy between
Cpt1a mRNA levels and FAO at the highest does of GPNA might be due to toxicity of the drug on primary cells at such high doses.
Indeed, when repeating this experiment in both an immortalized mouse hepatocyte cell line AML-12 (Figure 2f ) and the TGR-1 rat fibroblast cell line (Supporting Information Figure S4 ), we observed an increase in Cpt1a expression and a concomitant elevation in FAO beyond the highest doses used with MHC.
Mammalian target of rapamycin has emerged as an important regulator of lipid homeostasis (Kennedy & Lamming, 2016; Lamming & Sabatini, 2013) . Our ability to recapitulate the effect of reduced MYC activity on FAO by treatment of primary cells with rapamycin, or through inhibition of SLC1A5-mediated glutamine uptake, implicates mTORC1 as an important link between MYC and FAO.
In agreement, S6K1 deletion in mice, which impairs one mTORC1-activated downstream pathway, enhanced FAO and protected animals from obesity (Um et al., 2004) . How mTORC1 regulates FAO is not fully understood. mTORC1, or its downstream effector S6K2, can positively affect PPARα activity by promoting the nuclear localization of nuclear receptor corepressor 1 (NCoR1) (Kim, Pyo, & Um, 2012; Sengupta, Peterson, Laplante, Oh, & Sabatini, 2010) , but more work is needed to understand the mechanistic details.
It would also be of interest to explore additional MYC-regulated feedback loops that may affect signaling pathways such as AMPK or IGF1, both of which display longevity-promoting changes in longlived Myc +/− mice.
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